MarketLens
Sign Up

Saba Capital's ECAT Sales: A Calculated Gambit in a Protracted Proxy War

3 months ago
SHARE THIS ON:

Saba Capital's ECAT Sales: A Calculated Gambit in a Protracted Proxy War

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•13 hours ago

Actively Managed ETFs Are Giving In to the Price War—To the Benefit of Investors

Actively managed ETFs are cutting fees amid a price war, benefiting investors with lower costs. The shift underscores growing competition in the ETF space, where modest fees have long been a key selli...
Stock News•3 weeks ago

Saba Opportunistically Hedged Closed-End Funds ETF (CEFS) Announces Changes to Distribution Rate and Frequency

Saba Opportunistically Hedged Closed-End Funds ETF (CEFS) will shift to quarterly distributions at a 12% annualized NAV rate, effective September 25, 2026, after sub-adviser Saba Capital recommended t...
News•2 months ago

Strive: Capitalizing On An Early Bitcoin Cycle Shift With Downside Protection

Strive's ASST surged to 1.69x mNAV, likely on a short squeeze, versus MSTR at 1.00x mNAV. ASST offers daily dividends and downside protection but limits upside; preferred SATA yields ~13% annually wit...

Breaking News

View All →

Top Headlines

View More →
Stock News•20 minutes ago

GOOGL, GOOG Investors Have Opportunity to Lead Alphabet Inc. Securities Fraud Lawsuit

Stock News•1 hour ago

CrowdStrike Holdings (CRWD) Laps the Stock Market: Here's Why

Stock News•1 hour ago

Nvidia (NVDA) Surpasses Market Returns: Some Facts Worth Knowing

Stock News•1 hour ago

Apple (AAPL) Stock Falls Amid Market Uptick: What Investors Need to Know

Stock News•1 hour ago

Palo Alto Networks (PANW) Laps the Stock Market: Here's Why